| 前收盘价格 | 17.83 |
| 成交量 | 942,335 |
| 预期市盈率 (P/E Forward) | 10.03 |
| 价格/销量 (P/S) | 4.31 |
| 股市价格/股市净资产 (P/B) | 2.11 |
| 52周波幅 |
| 营业利益率 (TTM) | -272.84% |
| 稀释每股收益 (EPS TTM) | -2.92 |
| 季度收入增长率 (YOY) | 33.80% |
| 总债务/股东权益 (D/E MRQ) | 51.91% |
| 流动比率 (MRQ) | 2.16 |
| 营业现金流 (OCF TTM) | -194.68 M |
| 杠杆自由现金流 (LFCF TTM) | -81.28 M |
| 资产报酬率 (ROA TTM) | -39.55% |
| 股东权益报酬率 (ROE TTM) | -679.15% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Sutro Biopharma, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-1.7
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -1.67 |
|
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 4.58% |
| 机构持股比例 | 75.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Perceptive Advisors Llc | 30 Jun 2026 | 1,304,846 |
| Bvf Inc/Il | 30 Jun 2026 | 1,251,788 |
| Affinity Asset Advisors, Llc | 30 Jun 2026 | 1,172,487 |
| Samsara Biocapital, Llc | 30 Jun 2026 | 1,062,872 |
| Kynam Capital Management, Lp | 30 Jun 2026 | 872,558 |
| Orbimed Advisors Llc | 30 Jun 2026 | 743,944 |
| Balyasny Asset Management L.P. | 30 Jun 2026 | 711,162 |
| Eventide Asset Management, Llc | 30 Jun 2026 | 585,262 |
| Velan Capital Investment Management Lp | 30 Jun 2026 | 512,160 |
| Woodline Partners Lp | 30 Jun 2026 | 458,029 |
| Adar1 Capital Management, Llc | 30 Jun 2026 | 404,014 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合